Your browser doesn't support javascript.
loading
Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018.
Rosenblum, Hannah G; Lewis, Rayleen M; Gargano, Julia W; Querec, Troy D; Unger, Elizabeth R; Markowitz, Lauri E.
Afiliación
  • Rosenblum HG; Epidemic Intelligence Service and Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia (H.G.R.).
  • Lewis RM; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, and Synergy America, Duluth, Georgia (R.M.L.).
  • Gargano JW; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia (J.W.G., L.E.M.).
  • Querec TD; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia (T.D.Q., E.R.U.).
  • Unger ER; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia (T.D.Q., E.R.U.).
  • Markowitz LE; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia (J.W.G., L.E.M.).
Ann Intern Med ; 175(7): 918-926, 2022 07.
Article en En | MEDLINE | ID: mdl-35576590

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por Papillomavirus / Vacunas contra Papillomavirus Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Ann Intern Med Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por Papillomavirus / Vacunas contra Papillomavirus Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Ann Intern Med Año: 2022 Tipo del documento: Article